Figure 4
Figure 4. Expression of human KIT protein in the transplanted mice. (A) Leukemic cells from spleens of mice transplanted with Cbfb+/56m; Tg(Mx1-Cre)/KITD816V or Cbfb+/56m; Tg(Mx1-Cre)/KITD816Y BM cells. (B) Splenocytes from a mouse (nonleukemic) transplanted with Cbfb+/56m; Tg(Mx1-Cre)/KIT wt BM cells. (C) Leukemia cell line ME-1. The cells in panels A-C were stained with an anti–human KIT antibody and analyzed by FACS. In panels A through C, the cells in the left-hand panels were unstained and those in the right-hand panels were stained with the anti–human KIT. Cells in the boxes are GFP+ and human KIT+. (D) Western blot of leukemic spleen cells from Cbfb+/56m; Tg(Mx1-Cre)/KITD816Y (MxCre-CM + KIT mu) and Cbfb+/56m; Tg(Mx1-Cre) (MxCre-CM) mice using the anti–human KIT antibody. Actin was probed as the loading control.

Expression of human KIT protein in the transplanted mice. (A) Leukemic cells from spleens of mice transplanted with Cbfb+/56m; Tg(Mx1-Cre)/KITD816V or Cbfb+/56m; Tg(Mx1-Cre)/KITD816Y BM cells. (B) Splenocytes from a mouse (nonleukemic) transplanted with Cbfb+/56m; Tg(Mx1-Cre)/KIT wt BM cells. (C) Leukemia cell line ME-1. The cells in panels A-C were stained with an anti–human KIT antibody and analyzed by FACS. In panels A through C, the cells in the left-hand panels were unstained and those in the right-hand panels were stained with the anti–human KIT. Cells in the boxes are GFP+ and human KIT+. (D) Western blot of leukemic spleen cells from Cbfb+/56m; Tg(Mx1-Cre)/KITD816Y (MxCre-CM + KIT mu) and Cbfb+/56m; Tg(Mx1-Cre) (MxCre-CM) mice using the anti–human KIT antibody. Actin was probed as the loading control.

Close Modal

or Create an Account

Close Modal
Close Modal